Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| PBIGF (Paradigm Biopharmaceuticals Limited) | NA | 5.88% | -41.08% | -39.44% | NA | NA | NA | … | … |
Data as of 09/26/2025, Common starting date is 05/13/2019
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| PBIGF (Paradigm Biopharmaceuticals Limited) | 05/13/2019 | 09/26/2025 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 0.00 | 5.88 | -41.08 | -39.44 | NA | NA | NA | … | … | -33.33 | -48.15 | -72.16 | -32.64 | -20.00 | -9.55 | 89.52 |
| Sharpe Ratio | NA | 0.02 | -0.45 | -0.50 | NA | NA | NA | … | … | -0.34 | -0.88 | -1.06 | -0.41 | -0.53 | -0.08 | 1.67 |
| Standard Deviation(%) | NA | 137.17 | 98.42 | 83.75 | NA | NA | NA | … | … | 132.18 | 62.39 | 72.17 | 83.90 | 38.05 | 127.49 | 102.30 |
| Draw Down(%) | NA | 65.79 | 91.91 | 95.02 | NA | NA | NA | … | … | 65.79 | 59.26 | 80.88 | 53.47 | 29.03 | 71.33 | 11.61 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 09/26/2025, Common starting date is 05/13/2019
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| PBIGF (Paradigm Biopharmaceuticals Limited) |
-56.60%
Sep 2021 – Sep 2024 |
-39.44%
Aug 2020 – Aug 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| PBIGF (Paradigm Biopharmaceuticals Limited) |
5.73%
Oct 2019 – Oct 2022 |
-15.07%
Mar 2020 – Mar 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart